Suppr超能文献

用于移植的病毒载体基因治疗——已实现了多少承诺?

Gene therapy for transplantation with viral vectors--how much of the promise has been realised?

作者信息

Tan Peng H, Tan Peck L, George Andrew J T, Chan Christopher L H

机构信息

Oxford Transplant Centre, Oxford Radcliffe Hospitals NHS Trust, Oxford University, Churchill Hospital, Old Road, Oxford, OX3 7LJ, UK.

出版信息

Expert Opin Biol Ther. 2006 Aug;6(8):759-72. doi: 10.1517/14712598.6.8.759.

Abstract

Gene therapy holds promise in preventing the development of many diseases. One of the possible applications is the management of organ transplantation. Over the years, advances in vector development have allowed the clinical progression of this form of therapy to become more attainable. Viral vector technology has proved to be better than non-viral vectors at ferrying therapeutic genes to cells. However, many deficiencies in viral vectors hinder the full realisation of gene-based therapy in transplantation. Here, these deficiencies and their ramifications for the future of viral vector development are fully analysed. The authors propose that the slow progress of gene therapy in transplantation may be related to the deficiencies in viral vectors.

摘要

基因治疗在预防多种疾病的发展方面具有前景。其中一个可能的应用是器官移植的管理。多年来,载体开发的进展使这种治疗形式的临床进展变得更可实现。在将治疗性基因运送到细胞方面,病毒载体技术已被证明比非病毒载体更好。然而,病毒载体中的许多缺陷阻碍了基于基因的治疗在移植中的全面实现。在此,对这些缺陷及其对病毒载体开发未来的影响进行了全面分析。作者提出,基因治疗在移植中进展缓慢可能与病毒载体的缺陷有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验